122 related articles for article (PubMed ID: 24989452)
1. Incidence of late-onset pneumonia in patients after treatment with radiotherapy for nasopharyngeal carcinoma: A nationwide population-based study.
Yen TT; Lin CH; Jiang RS; Shih YT; Yen HR; Liang KL
Head Neck; 2015 Dec; 37(12):1756-61. PubMed ID: 24989452
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for recurrent pneumonia in post-irradiated patients with nasopharyngeal carcinoma.
Wang JJ; Jiang RS; Yen TT; Liang KL
J Chin Med Assoc; 2017 Sep; 80(9):558-562. PubMed ID: 28487142
[TBL] [Abstract][Full Text] [Related]
3. External auditory canal cholesteatoma in patients given radiotherapy for nasopharyngeal carcinoma.
Yu SS; Lee KJ; Lin YS
Head Neck; 2015 Dec; 37(12):1794-8. PubMed ID: 24989318
[TBL] [Abstract][Full Text] [Related]
4. Risk of ocular complications following radiation therapy in patients with nasopharyngeal carcinoma.
Lin KT; Lee SY; Liu SC; Tsao CC; Hsu SD; Chien WC; Chung CH; Chang WK; Chen YW; Lin CS
Laryngoscope; 2020 May; 130(5):1270-1277. PubMed ID: 31441954
[TBL] [Abstract][Full Text] [Related]
5. Risk of developing sudden sensorineural hearing loss in patients with nasopharyngeal carcinoma: a population-based cohort study.
Lin C; Lin SW; Weng SF; Lin YS
Head Neck; 2014 Feb; 36(2):203-8. PubMed ID: 23780872
[TBL] [Abstract][Full Text] [Related]
6. Young nasopharyngeal cancer patients with radiotherapy and chemotherapy are most prone to ischaemic risk of stroke: a national database, controlled cohort study.
Chu CN; Chen PC; Bai LY; Muo CH; Sung FC; Chen SW
Clin Otolaryngol; 2013 Feb; 38(1):39-47. PubMed ID: 23194286
[TBL] [Abstract][Full Text] [Related]
7. Nasopharyngeal carcinoma in a low incidence European area : A prospective observational analysis from the Head and Neck Study Group of the Italian Society of Radiation Oncology (AIRO).
Tonoli S; Alterio D; Caspiani O; Bacigalupo A; Bunkheila F; Cianciulli M; Merlotti A; Podhradska A; Rampino M; Cante D; Bruschieri L; Gatta R; Magrini SM
Strahlenther Onkol; 2016 Dec; 192(12):931-943. PubMed ID: 27761611
[TBL] [Abstract][Full Text] [Related]
8. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.
Chen L; Hu CS; Chen XZ; Hu GQ; Cheng ZB; Sun Y; Li WX; Chen YY; Xie FY; Liang SB; Chen Y; Xu TT; Li B; Long GX; Wang SY; Zheng BM; Guo Y; Sun Y; Mao YP; Tang LL; Chen YM; Liu MZ; Ma J
Lancet Oncol; 2012 Feb; 13(2):163-71. PubMed ID: 22154591
[TBL] [Abstract][Full Text] [Related]
9. Aspiration pneumonia in patients treated with radiotherapy for head and neck cancer.
Mortensen HR; Jensen K; Grau C
Acta Oncol; 2013 Feb; 52(2):270-6. PubMed ID: 23173758
[TBL] [Abstract][Full Text] [Related]
10. Risk of hypothyroidism among patients with nasopharyngeal carcinoma treated with radiation therapy: A Population-Based Cohort Study.
Fan CY; Lin CS; Chao HL; Huang WY; Su YF; Lin KT; Tsai IJ; Kao CH
Radiother Oncol; 2017 Jun; 123(3):394-400. PubMed ID: 28532605
[TBL] [Abstract][Full Text] [Related]
11. Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials.
Du CR; Ying HM; Kong FF; Zhai RP; Hu CS
Radiat Oncol; 2015 Mar; 10():70. PubMed ID: 25889937
[TBL] [Abstract][Full Text] [Related]
12. High case volume of radiation oncologists is associated with better survival of nasopharyngeal carcinoma patients treated with radiotherapy: a multifactorial cohort analysis.
Chien CR; Lin HW; Yang CH; Yang SN; Wang YC; Kuo YC; Chen SW; Liang JA
Clin Otolaryngol; 2011 Dec; 36(6):558-65. PubMed ID: 22023959
[TBL] [Abstract][Full Text] [Related]
13. T4/N2 classification nasopharyngeal carcinoma benefit from concurrent chemotherapy in the era of intensity-modulated radiotherapy.
Xie R; Xia B; Zhang X; Hu W; Zhao R; Xie C; Wang J; Zhang N; Wu S
Oncotarget; 2016 Dec; 7(49):81918-81925. PubMed ID: 27636993
[TBL] [Abstract][Full Text] [Related]
14. Risk of swallowing-related chest infections in patients with nasopharyngeal carcinoma treated with definitive intensity-modulated radiotherapy.
Xiong J; Krishnaswamy G; Raynor S; Loh KS; Kwa AL; Lim CM
Head Neck; 2016 Apr; 38 Suppl 1():E1660-5. PubMed ID: 26891064
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
Lee AWM; Tung SY; Ng WT; Lee V; Ngan RKC; Choi HCW; Chan LLK; Siu LL; Ng AWY; Leung TW; Yiu HHY; O'Sullivan B; Chappell R
Cancer; 2017 Nov; 123(21):4147-4157. PubMed ID: 28662313
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.
Kawai S; Yokota T; Onozawa Y; Hamauchi S; Fukutomi A; Ogawa H; Onoe T; Onitsuka T; Yurikusa T; Todaka A; Tsushima T; Yoshida Y; Kito Y; Mori K; Yasui H
BMC Cancer; 2017 Jan; 17(1):59. PubMed ID: 28095814
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
18. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer.
Xu B; Boero IJ; Hwang L; Le QT; Moiseenko V; Sanghvi PR; Cohen EE; Mell LK; Murphy JD
Cancer; 2015 Apr; 121(8):1303-11. PubMed ID: 25537836
[TBL] [Abstract][Full Text] [Related]
19. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China.
Chen Y; Sun Y; Liang SB; Zong JF; Li WF; Chen M; Chen L; Mao YP; Tang LL; Guo Y; Lin AH; Liu MZ; Ma J
Cancer; 2013 Jun; 119(12):2230-8. PubMed ID: 23576020
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
Ke LR; Xia WX; Qiu WZ; Huang XJ; Yang J; Yu YH; Liang H; Liu GY; Ye YF; Xiang YQ; Guo X; Lv X
BMC Cancer; 2017 Feb; 17(1):134. PubMed ID: 28202000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
